(Q34531508)

2 August 2017

1 reference

title

Advanced cardiac life support antiarrhythmic drugs (English)

1 reference

2 August 2017

Peter J Kudenchuk

1

1 reference

2 August 2017

publication date

1 February 2002

1 reference

2 August 2017

1 reference

2 August 2017

volume

20

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

79-87

1 reference

Considerations for improving survival from out-of-hospital cardiac arrest

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Estimating effectiveness of cardiac arrest interventions: a logistic regression survival model

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Survival in patients found to have ventricular fibrillation after cardiac arrest witnessed outside hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Rhythm changes during resuscitation from ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Resuscitation outside the hospital--what's lacking?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

The use of antiarrhythmics in advanced cardiac life support

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

The coronary care unit. New perspectives and directions

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Ventricular fibrillation precipitated by cardiac catheterization; complete recovery of the patient after 45 minutes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Reconsiderations of the routine and preferential use of lidocaine in the emergent treatment of ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Electrophysiological properties of canine Purkinje cells in one-day-old myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Effects of lidocaineine on hypoxic and ischemic cardiac cells

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Beneficial effect of lidocaine on ventricular electrical stability and spontaneous ventricular fibrillation during experimental myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Effect of lidocaine on the ventricular fibrillation threshold in the dog during acute ischemia and premature ventricular contractions.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Mechanism of the myocardial effects of bretylium

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

The effect of bretylium tosylate on the electrophysiologic properties of ventricular muscle and purkinje fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

The role of magnesium in cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

The use of intravenous amiodarone in the acute therapy of life-threatening tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Evaluation of drugs for cardiac resuscitation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Resuscitation from ventricular fibrillation. Drug therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Deleterious effects of bretylium on hemodynamic recovery from ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Effects of amiodarone on refractory ventricular fibrillation in acute myocardial infarction: experimental study.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Elevation of ventricular defibrillation threshold in dogs by antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Effect of procainamide on fibrillation threshold of normal and ischemic ventricles

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Effect of lidocaine and bretylium on energy requirements for transthoracic defibrillation: experimental studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Lidocaine causes a reversible, concentration-dependent increase in defibrillation energy requirements.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

The effect of newer antiarrhythmic drugs on defibrillation threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Effects of amiodarone and its active metabolite desethylamiodarone on the ventricular defibrillation threshold.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Lidocaine in out-of-hospital ventricular fibrillation. Does it improve survival?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Lidocaine in prehospital countershock refractory ventricular fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Do advanced cardiac life support drugs increase resuscitation rates from in-hospital cardiac arrest? The OTAC Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Chemical ventricular defibrillation of the human heart with bretylium tosylate

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Bretylium tosylate as initial treatment for cardiopulmonary arrest: randomized comparison with placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Comparison of bretylium tosylate and lidocaine in management of out of hospital ventricular fibrillation: a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

A randomized comparison study of bretylium tosylate and lidocaine in resuscitation of patients from out-of-hospital ventricular fibrillation in a paramedic system.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Grou

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Efficacy of bretylium tosylate for ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Intermittent intravenous procaine amide to treat ventricular arrhythmias. Correlation of plasma concentration with effect on arrhythmia, electrocardiogram, and blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Comparative electrophysiologic effects of intravenous and oral procainamide in patients with sustained ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Effects of procainamide and lidocaine on electrically inducible ventricular tachycardia studied with programmed ventricular stimulation in post myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Dissociation of termination and prevention of inducibility of sustained ventricular tachycardia with infusion of procainamide: Evidence for distinct mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Effect of loading dose of procaine amide on left ventricular performance in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Association of drug therapy with survival in cardiac arrest: limited role of advanced cardiac life support drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Treatment of torsade de pointes with magnesium sulfate.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Limited effect of magnesium sulphate on torsades de pointes ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Magnesium in cardiac arrest (the magic trial)

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Magnesium levels in cardiac arrest victims: relationship between magnesium levels and successful resuscitation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

Amiodarone in out-of-hospital cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2803%2900066-3

7 January 2021

10.1016/S0733-8651(03)00066-3

Identifiers

DOI

1 reference

2 August 2017

1 reference